MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Synchronized High Frequency Neural Oscillations as a Biomarker for Differentiating the Internal from the External Segment of the Globus Pallidus in Parkinson’s Disease

    J. Aman, K. O'Neill, S. Safo, M. Hill, S. Alberico, R. Cole, L. Johnson, J. Wang, K. Domingo, L. de Almeida, S. Cooper, D. Darrow, R. Mcgovern Iii, M. Park, L. Eberly, J. Vitek (Minneapolis, USA)

    Objective: To assess whether using high frequency oscillations (HFO; 150-350 Hz) or beta band oscillations (13-30 Hz) can objectively differentiate the external from the internal…
  • 2025 International Congress

    Dopamine replacement therapy modulates dopa decarboxylase, prolactin and AOC3 levels in Parkinson’s disease

    L. van Hillegondsberg, S. Ahmad, M. Fletcher, A. Taylor, A. Thompson, M. Hu (Oxford, United Kingdom)

    Objective: Investigate the impact of dopamine replacement therapy (DRT) on the serum and CSF proteome of people with Parkinson’s disease (PwPD). Background: New high-throughput technologies…
  • 2025 International Congress

    Paradoxical Association of Kinetics of α-Synuclein Seed Amplification 24-hrs Assay and Clinico-Pathological Markers of Parkinson’s disease

    SM. Fereshtehnejad, Y. Zeighami, C. Marras (TORONTO, Canada)

    Objective: To investigate the association between baseline α-synuclein seed amplification assay (SAA) parameters and clinical and biomarker features of Parkinson’s disease (PD) at baseline and…
  • 2025 International Congress

    Eye movement abnormalities in GBA1-related Parkinson’s disease and non-manifesting GBA1-carriers

    G. Riboldi, T. Hudson, H. Conn, K. Astudillo, J. Rizzo, S. Frucht, J. Rucker (New York, USA)

    Objective: To perform an in-depth characterization of eye movement abnormalities in Parkinson’s disease (PD) and non-manifesting carriers of GBA1 pathogenic variants. Background: Eye movement abnormalities…
  • 2025 International Congress

    Salivary Biomarkers in Parkinson’s Disease: A Follow-Up Study

    MI. de Bartolo, D. Belvisi, E. Patricolo, M. Costanzo, C. Cutrona, F. Aiello, G. Leodori, A. Conte, G. Fabbrini, A. Berardelli, G. Vivacqua (Rome, Italy)

    Objective: Investigate longitudinal changes in salivary levels of oligomeric and total a-synuclein (a-syn), phosphorylated-tau (p-tau), total tau, MAP-LC3, and TNFa in Parkinson’s Disease (PD) patientsAssess…
  • 2025 International Congress

    Alpha-Synuclein Preformed Fibrils Increase the Frequency of CXCR3+ B-cells in Early-stage Parkinson’s Disease Patients

    H. Hong, M. Dean, D. Standaert, H. Qin, E. Benveniste (Birmingham, USA)

    Objective: To investigate the effect of a-Syn Preformed Fibrils (PFF) on CXCR3 expression on B-cells in Parkinson’s Disease (PD) patients at early (E-PD, diagnosed less…
  • 2025 International Congress

    Factors contributing to balance discordance and its impact on fear of falling avoidance behavior in Parkinson’s disease

    S. Conklin, D. Peterson, A. Hooyman, J. Longhurst (Saint Louis, USA)

    Objective: To identify cognitive and psychological factors contributing to balance discordance in people with Parkinson's disease (PwPD) and examine how it is associated with fear…
  • 2025 International Congress

    GPi Lesioning vs. DBS: Does Targeting the Same Structure Differently Affect Cognition in Parkinson’s Disease?

    J. Brainer, P. Brainer, S. Laurentino, M. Cavalcanti, A. Oliveira, A. Brainer, P. Brainer (Recife, Brazil)

    Objective: To compare the cognitive and quality of life (QoL) outcomes of GPi-DBS and GPi-RF, investigating whether lesion-based approaches pose a greater cognitive burden over…
  • 2025 International Congress

    Approaches to understanding the role of STN in the development of ICD in Parkinson’s disease

    A. Buniak, V. Bayarchyk, A. Mikitchuk (Minsk, Belarus)

    Objective: The aim of this study was to identify the features of subthalamic tracts in PD patients with ICD. Background: Recurrent negative feedback loops from…
  • 2025 International Congress

    Cognitive Decline in Parkinson’s Disease: A Decade-Long Registry Analysis of Prevalence and Risk Factors

    L. Ge, K. Asai, K. Ogawa, K. Ikenaka, Y. Kimura, H. Mochizuki (Suita, Japan)

    Objective: This study aims to identify predictors of cognitive decline in cognitively normal Parkinson’s disease patients by analyzing the 10 years-long PD registry. Background: Cognitive…
  • « Previous Page
  • 1
  • …
  • 170
  • 171
  • 172
  • 173
  • 174
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley